Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Axsome Therapeutics Inc.

    NASDAQ: AXSM · Real-Time Price · USD
    109.20
    0.45 (0.41%)
    At close: Aug 15, 2025, 3:44 PM

    Axsome Therapeutics Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 385.69M 270.6M 50.04M n/a
    Cost of Revenue
    		 33.3M 26.07M 5.2M 1.16M
    Gross Profit
    		 352.39M 244.53M 44.84M -1.16M
    Operating Income
    		 -280.56M -231.82M -176.5M -124.71M
    Interest Income
    		 n/a n/a n/a 5.7M
    Pretax Income
    		 -287.13M -238.28M -187.13M -130.4M
    Net Income
    		 -287.22M -239.24M -197.77M -134.94M
    Selling & General & Admin
    		 411.36M 323.12M 159.25M 66.65M
    Research & Development
    		 187.08M 97.94M 57.95M 58.06M
    Other Expenses
    		 34.52M 55.29M 4.14M n/a
    Operating Expenses
    		 632.95M 476.36M 221.34M 124.71M
    Interest Expense
    		 6.57M 6.45M 7.33M 5.7M
    Selling & Marketing Expenses
    		 n/a 100.3M 35.3M n/a
    Cost & Expenses
    		 666.25M 502.43M 226.54M 124.71M
    Income Tax Expense
    		 85K 960K 10.63M n/a
    Shares Outstanding (Basic)
    		 47.91M 45.43M 40.66M 37.62M
    Shares Outstanding (Diluted)
    		 47.91M 45.43M 40.66M 37.62M
    EPS (Basic)
    		 -5.99 -5.27 -4.86 -3.59
    EPS (Diluted)
    		 -5.99 -5.27 -4.86 -3.59
    EBITDA
    		 -272.6M -224.99M -174.23M -123.55M
    EBIT
    		 -280.56M -231.82M -179.8M -124.71M
    Depreciation & Amortization
    		 7.96M 6.83M 5.56M 1.16M

    Add to Watchlist